Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung…
NCT00041314 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00041314 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | A Phase II Trial Of Carboplatin And Gemcitabine With Exisulind In Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, exisulind, gemcitabine hydrochloride |
| Start date | Oct 4, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jun 15, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | Australia, Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: